HAEMORRHAGE IN PREGNANCY

HAEMORRHAGE IN PREGNANCY was reported 1434 times

HAEMORRHAGE IN PREGNANCY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Blood Coagulation Factor [EPC] 2 0.0024
1 Progestin [EPC] 467 0.0016
2 Prostaglandin E1 Analog [EPC] 25 0.0015
3 Interleukin-5 Antagonist [EPC] 1 0.0015
4 Oxytocic [EPC] 4 0.0013
5 Progesterone [EPC] 29 0.0012
6 Anthelmintic [EPC] 2 0.0007
7 Copper-containing Intrauterine Device [EPC] 30 0.0006
8 Provitamin D2 Compound [EPC] 18 0.0006
9 Human Immunoglobulin G [EPC] 12 0.0006
10 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 4 0.0005
11 Gonadotropin [EPC] 1 0.0005
12 Purine Antimetabolite [EPC] 45 0.0005
13 Integrin Receptor Antagonist [EPC] 35 0.0004
14 Vitamin K [EPC] 3 0.0003
15 Bile Acid Sequestrant [EPC] 4 0.0003
16 Antifibrinolytic Agent [EPC] 3 0.0003
17 Interferon beta [EPC] 51 0.0003
18 Aminosalicylate [EPC] 26 0.0003
19 Vitamin D [EPC] 78 0.0003
20 Human C1 Esterase Inhibitor [EPC] 1 0.0003
21 Vitamin B12 [EPC] 81 0.0002
22 Blood Viscosity Reducer [EPC] 1 0.0002
23 Progestin Antagonist [EPC] 1 0.0002
24 Thyroid Hormone Synthesis Inhibitor [EPC] 2 0.0002
25 Vitamin C [EPC] 79 0.0002
26 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 9 0.0002
27 Protease Inhibitor [EPC] 8 0.0002
28 B Lymphocyte Stimulator-specific Inhibitor [EPC] 5 0.0002
29 Serotonin Reuptake Inhibitor [EPC] 14 0.0002
30 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 16 0.0001
31 Sphingosine 1-phosphate Receptor Modulator [EPC] 2 0.0001
32 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1 0.0001
33 Cytochrome P450 3A Inhibitor [EPC] 8 0.0001
34 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1 0.0001
35 Anticholinergic [EPC] 2 0.0001
36 Typical Antipsychotic [EPC] 3 0.0001
37 Phenylalanine Metabolizing Enzyme [EPC] 1 0.0001
38 Antidote [EPC] 7 0.0001
39 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
40 Polyene Antifungal [EPC] 4 0.0001
41 Complement Inhibitor [EPC] 5 0.0001
42 Bile Acid [EPC] 2 0.0001
43 Anti-epileptic Agent [EPC] 19 0.0001
44 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
45 Cholinergic Nicotinic Agonist [EPC] 5 0.0001
46 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 2 0.0001
47 Lipid-based Polyene Antifungal [EPC] 1 0.0001
48 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
49 Estrogen [EPC] 14 0.0001
50 Calcium [EPC] 11 0.0001
51 Catecholamine [EPC] 6 0.0001
52 Parenteral Iron Replacement [EPC] 1 0.0001
53 Proton Pump Inhibitor [EPC] 42 0.0001
54 Azole Antifungal [EPC] 11 0.0001
55 Stimulant Laxative [EPC] 1 0.0001
56 Phenothiazine [EPC] 2 0.0001
57 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
58 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 6 0.0001
59 Atypical Antipsychotic [EPC] 28 0.0001
60 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1 0.0001
61 Nitroimidazole Antimicrobial [EPC] 4 0.0001
62 Histamine-1 Receptor Antagonist [EPC] 5 0.0001
63 Mood Stabilizer [EPC] 13 0.0001
64 Tumor Necrosis Factor Blocker [EPC] 58 0.0001
65 CD20-directed Cytolytic Antibody [EPC] 18 0.0001
66 Nitrofuran Antibacterial [EPC] 1 0.0001
67 Janus Kinase Inhibitor [EPC] 9 0.0001
68 Rifamycin Antibacterial [EPC] 2 0.0001
69 Platelet Aggregation Inhibitor [EPC] 30 0.0001
70 Cholinergic Muscarinic Antagonist [EPC] 2 0.0001
71 Vitamin D3 Analog [EPC] 1 0.0000
72 Corticosteroid [EPC] 62 0.0000
73 Interleukin-23 Antagonist [EPC] 5 0.0000
74 Nonsteroidal Anti-inflammatory Drug [EPC] 62 0.0000
75 Amide Local Anesthetic [EPC] 4 0.0000
76 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
77 Aromatase Inhibitor [EPC] 5 0.0000
78 Insulin [EPC] 2 0.0000
79 Antimycobacterial [EPC] 1 0.0000
80 Ester Local Anesthetic [EPC] 2 0.0000
81 PCSK9 Inhibitor [EPC] 1 0.0000
82 Radiographic Contrast Agent [EPC] 1 0.0000
83 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
84 Antirheumatic Agent [EPC] 4 0.0000
85 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
86 Folate Analog Metabolic Inhibitor [EPC] 16 0.0000
87 Selective T Cell Costimulation Modulator [EPC] 5 0.0000
88 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
89 Anti-IgE [EPC] 3 0.0000
90 Methylxanthine [EPC] 2 0.0000
91 Central Nervous System Stimulant [EPC] 3 0.0000
92 Leukotriene Receptor Antagonist [EPC] 1 0.0000
93 Iron Chelator [EPC] 1 0.0000
94 Expectorant [EPC] 7 0.0000
95 Sympathomimetic-like Agent [EPC] 1 0.0000
96 Antiarrhythmic [EPC] 3 0.0000
97 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
98 Factor Xa Inhibitor [EPC] 8 0.0000
99 Insulin Analog [EPC] 13 0.0000
100 Retinoid [EPC] 7 0.0000
101 Leukocyte Growth Factor [EPC] 4 0.0000
102 Non-Standardized Chemical Allergen [EPC] 2 0.0000
103 Opioid Agonist [EPC] 7 0.0000
104 Thiazide Diuretic [EPC] 5 0.0000
105 Aminoglycoside Antibacterial [EPC] 1 0.0000
106 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
107 Muscle Relaxant [EPC] 1 0.0000
108 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
109 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
110 Benzodiazepine [EPC] 14 0.0000
111 Angiotensin 2 Receptor Blocker [EPC] 6 0.0000
112 beta-Adrenergic Blocker [EPC] 5 0.0000
113 Nicotinic Acid [EPC] 1 0.0000
114 Fluoroquinolone Antibacterial [EPC] 2 0.0000
115 Glycopeptide Antibacterial [EPC] 1 0.0000
116 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
117 Topoisomerase Inhibitor [EPC] 1 0.0000
118 Alkylating Drug [EPC] 3 0.0000
119 Phosphodiesterase 4 Inhibitor [EPC] 2 0.0000
120 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
121 Loop Diuretic [EPC] 5 0.0000
122 Partial Opioid Agonist [EPC] 1 0.0000
123 Osmotic Laxative [EPC] 3 0.0000
124 Interleukin-12 Antagonist [EPC] 1 0.0000
125 Sulfonylurea [EPC] 1 0.0000
126 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
127 Prostacycline Vasodilator [EPC] 1 0.0000
128 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
129 GLP-1 Receptor Agonist [EPC] 3 0.0000
130 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
131 Endothelin Receptor Antagonist [EPC] 1 0.0000
132 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
133 Platinum-based Drug [EPC] 1 0.0000
134 Kinase Inhibitor [EPC] 1 0.0000